These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 33835301)

  • 41. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
    Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
    Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pancreatic cancer detection and characterization-state of the art cross-sectional imaging and imaging data analysis.
    Kaissis G; Braren R
    Transl Gastroenterol Hepatol; 2019; 4():35. PubMed ID: 31231702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine.
    Rossi G; Ignatiadis M
    Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach.
    Kay K; Dolcy K; Bies R; Shah DK
    AAPS J; 2019 Feb; 21(2):27. PubMed ID: 30737615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreas Cancer-Associated Weight Loss.
    Hendifar AE; Petzel MQB; Zimmers TA; Denlinger CS; Matrisian LM; Picozzi VJ; Rahib L;
    Oncologist; 2019 May; 24(5):691-701. PubMed ID: 30591550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    Conroy T; Hammel P; Hebbar M; Ben Abdelghani M; Wei AC; Raoul JL; Choné L; Francois E; Artru P; Biagi JJ; Lecomte T; Assenat E; Faroux R; Ychou M; Volet J; Sauvanet A; Breysacher G; Di Fiore F; Cripps C; Kavan P; Texereau P; Bouhier-Leporrier K; Khemissa-Akouz F; Legoux JL; Juzyna B; Gourgou S; O'Callaghan CJ; Jouffroy-Zeller C; Rat P; Malka D; Castan F; Bachet JB;
    N Engl J Med; 2018 Dec; 379(25):2395-2406. PubMed ID: 30575490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered exocrine function can drive adipose wasting in early pancreatic cancer.
    Danai LV; Babic A; Rosenthal MH; Dennstedt EA; Muir A; Lien EC; Mayers JR; Tai K; Lau AN; Jones-Sali P; Prado CM; Petersen GM; Takahashi N; Sugimoto M; Yeh JJ; Lopez N; Bardeesy N; Fernandez-Del Castillo C; Liss AS; Koong AC; Bui J; Yuan C; Welch MW; Brais LK; Kulke MH; Dennis C; Clish CB; Wolpin BM; Vander Heiden MG
    Nature; 2018 Jun; 558(7711):600-604. PubMed ID: 29925948
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cachexia, and not obesity, prior to pancreatic cancer diagnosis worsens survival and is negated by chemotherapy.
    Hendifar AE; Chang JI; Huang BZ; Tuli R; Wu BU
    J Gastrointest Oncol; 2018 Feb; 9(1):17-23. PubMed ID: 29564167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions.
    Nemer L; Krishna SG; Shah ZK; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Guttridge DC; Hinton A; Manilchuk A; Pawlik TM; Schmidt CR; Talbert EE; Bekaii-Saab T; Hart PA
    Pancreas; 2017 Oct; 46(9):1152-1157. PubMed ID: 28902785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Bibbins-Domingo K; Grossman DC; Curry SJ; Davidson KW; Epling JW; García FAR; Gillman MW; Harper DM; Kemper AR; Krist AH; Kurth AE; Landefeld CS; Mangione CM; Owens DK; Phillips WR; Phipps MG; Pignone MP; Siu AL
    JAMA; 2016 Jun; 315(23):2564-2575. PubMed ID: 27304597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening.
    Wu D; Zhou G; Jin P; Zhu J; Li S; Wu Q; Wang G; Sheng J; Wang J; Song L; Han X; Qian J
    J Mol Diagn; 2016 Jul; 18(4):535-45. PubMed ID: 27133379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.
    Paniccia A; Hosokawa P; Henderson W; Schulick RD; Edil BH; McCarter MD; Gajdos C
    JAMA Surg; 2015 Aug; 150(8):701-10. PubMed ID: 26062046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer cachexia, mechanism and treatment.
    Aoyagi T; Terracina KP; Raza A; Matsubara H; Takabe K
    World J Gastrointest Oncol; 2015 Apr; 7(4):17-29. PubMed ID: 25897346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.
    Peixoto RD; Speers C; McGahan CE; Renouf DJ; Schaeffer DF; Kennecke HF
    Cancer Med; 2015 Aug; 4(8):1171-7. PubMed ID: 25891650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages.
    Yu J; Blackford AL; Dal Molin M; Wolfgang CL; Goggins M
    Gut; 2015 Nov; 64(11):1783-9. PubMed ID: 25636698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involuntary weight loss.
    Wong CJ
    Med Clin North Am; 2014 May; 98(3):625-43. PubMed ID: 24758965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer.
    Pausch T; Hartwig W; Hinz U; Swolana T; Bundy BD; Hackert T; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S81-8. PubMed ID: 22770957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
    Conroy T; Desseigne F; Ychou M; Bouché O; Guimbaud R; Bécouarn Y; Adenis A; Raoul JL; Gourgou-Bourgade S; de la Fouchardière C; Bennouna J; Bachet JB; Khemissa-Akouz F; Péré-Vergé D; Delbaldo C; Assenat E; Chauffert B; Michel P; Montoto-Grillot C; Ducreux M; ;
    N Engl J Med; 2011 May; 364(19):1817-25. PubMed ID: 21561347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating diagnostic strategy of older patients with unexplained unintentional body weight loss: a hospital-based study.
    Wu JM; Lin MH; Peng LN; Chen LK; Hwang SJ
    Arch Gerontol Geriatr; 2011; 53(1):e51-4. PubMed ID: 21071102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distant metastasis occurs late during the genetic evolution of pancreatic cancer.
    Yachida S; Jones S; Bozic I; Antal T; Leary R; Fu B; Kamiyama M; Hruban RH; Eshleman JR; Nowak MA; Velculescu VE; Kinzler KW; Vogelstein B; Iacobuzio-Donahue CA
    Nature; 2010 Oct; 467(7319):1114-7. PubMed ID: 20981102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.